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NEONATAL ABSTINENCE SYNDROME
Marissa Thompson, BSN Student, Barbara McClaskey, Ph.D. – Faculty
Irene Ransom Bradley School of Nursing, Pittsburg State University

INTRODUCTION
Neonatal Abstinence Syndrome (NAS) is a
rising concern in infants.This is due to more
women taking narcotics while they are
pregnant. Approximately 21,732 infants were
diagnosed with Neonatal Abstinence Syndrome
in 2012. Since then, the number has increased
by five times.There is no definitive
standardized care for NAS. Studies have been
done to look at whether or not standardizing
care influences the length of stay and the
length of pharmacologic therapy in infants with
NAS.

MATERIALS / METHODS
❖

❖

PICOT
❖ Population: Infants with NAS
❖ Intervention: Standardizing care for
NAS in hospitals
❖ Comparison: No standardized care
❖ Outcome: Decrease in length of
pharmacological use & hospital stay

❖

❖ Time frame: From the time the infant
is born until they are discharged

PURPOSE
❖ The purpose of this study is to see if
standardizing care for infants born with
Neonatal Abstinence Syndrome (NAS)
helps decrease the length of
pharmacological treatment and the
overall hospital stay.

❖

Neonatal abstinence syndrome
❖
When a pregnant woman uses narcotics, they cross
the placenta to the fetus.The fetus then becomes
dependent on the drug. When an infant is born, they
are still dependent on the drug, however they are no
longer receiving it. Withdrawal occurs due to the
infant’s central nervous system becoming
overstimulated. Infants may experience tremors,
irritability, hyperactive reflexes, seizures, poor feeding
and suck, sweating or fever. 55% to 94% of infants
exposed to opioids in utero will have withdrawal
symptoms
Nationwide Children’s Hospital Study
❖
This hospital partnered with 5 other hospitals in Ohio
for this study.
❖
This study was done to develop a standardized
practice that focused on communication between
healthcare workers, improving reliability of the
Finnegan NAS scoring system & developing an
initiation and weaning protocol
❖
They found that compliance with standardized
protocol may be more significant than which specific
pharmacologic intervention is used
❖
When using methadone with a standardized
protocol, the length of stay was decreased
❖
NAS Taskforce developed
❖
Meet monthly
❖
Discuss problems related to the management of
NAS, ways to improve the processes & shared
improvements with other neonatal units
Yale New Haven’s Children Hospital Study
❖
Average length of stay for infants with NAS was 22.4
days without standardized treatment
❖
After implementing standardized care, the average
length of stay was 5.9 days
❖
Rapid morphine weaning & as-needed morphine
protocol established
❖
Infants treated with morphine decreased from
98% to 14%
Vermont Oxford Network Quality Improvement
Collaborative
❖
199 birthing centers and NICU’s participated
❖
Goal was to determine if these hospitals participating
had decreased length of stay and treatment for
infants with NAS
❖
Policies developed for standardized NAS scoring
increased from 44.8% to 76.5%
❖
Non-pharmacologic policies improved from 59.1% to
84.0%
❖
Standardized pharmacologic treatment increased
from 68% to 91.6%

INTERVENTIONS
❖
❖
❖
❖
❖
❖
❖

Using standardized guidelines for infants with
NAS
Using nonpharmacologic and pharmacologic
treatment
Using standardized medication weaning
guidelines
Identifying infants who are at risk for NAS
Educating women who are pregnant about the
risks of narcotic use during pregnancy
Using the Finnegan NAS scoring system
Having a taskforce to evaluate outcomes and
problems to provide the best care

RESULTS / CONCLUSION
❖
❖
❖
❖
❖

Following standardized treatment guidelines
for infants with NAS
Decreased length of stay in the hospital
Decreased length of pharmacologic
treatment
Using nonpharmacologic measures prior to
pharmacologic
Reliably using the scores of the Finnegan
NAS scoring system to determine correct
treatment options
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